Skip to main navigation
  • News & Investors

    News & Investors

    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact
  • Contact Us
Celsion
  • TECHNOLOGY
    • LTSL
    • TheraPlas
    • TheraSilence
  • PRODUCTS
    • ThermoDox
    • GEN-1
  • PIPELINE
    • Clinical Studies
    • Pre-clinical Programs
  • DISEASES
  • PUBLICATIONS
  • ABOUT US
    • Leadership
    • Board of Directors
    • Corporate Governance
Select Page

Insider Transactions

    Investor Relations

    • News & Investors
    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Insider Transactions
      • Stock Ownership
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact

Insider Transactions

Date Filer Title Type Shares Traded Price
Mar 19, 2021
Braun Donald P
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Mar 19, 2021
Chow Pok Yu Augustine
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Mar 19, 2021
CHURCH JEFFREY WAYNE
CFO Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 --
Mar 19, 2021
Fritz Frederick J.
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Mar 19, 2021
Hooper Robert W
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Mar 19, 2021
Tardugno Michael H
Director, Chairman, President and CEO Grant, award or other acquisition pursuant to Rule 16b-3(d) 650,000 --
Mar 19, 2021
Tumminello Timothy J
Controller Grant, award or other acquisition pursuant to Rule 16b-3(d) 65,000 --
Mar 19, 2021
Voss Andreas
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 --
Jun 15, 2020
Braun Donald P
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,000 --
Jun 15, 2020
Braun Donald P
Director Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 50,000 --
Jun 15, 2020
Braun Donald P
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jun 15, 2020
Chow Pok Yu Augustine
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,000 --
Jun 15, 2020
Chow Pok Yu Augustine
Director Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 70,000 --
Jun 15, 2020
Chow Pok Yu Augustine
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 70,000 --
Jun 15, 2020
CHURCH JEFFREY WAYNE
CFO Grant, award or other acquisition pursuant to Rule 16b-3(d) 55,000 --
Jun 15, 2020
CHURCH JEFFREY WAYNE
CFO Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 250,000 --
Jun 15, 2020
CHURCH JEFFREY WAYNE
CFO Grant, award or other acquisition pursuant to Rule 16b-3(d) 250,000 --
Jun 15, 2020
Fritz Frederick J.
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,000 --
Jun 15, 2020
Fritz Frederick J.
Director Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 70,000 --
Jun 15, 2020
Fritz Frederick J.
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 70,000 --
Jun 15, 2020
Hooper Robert W
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,000 --
Jun 15, 2020
Hooper Robert W
Director Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 70,000 --
Jun 15, 2020
Hooper Robert W
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 70,000 --
Jun 15, 2020
Martinez Alberto R Jr
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 4,000 --
Jun 15, 2020
Martinez Alberto R Jr
Director Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 70,000 --

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • Downloads
    • RSS
    • Print
    • Search

    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS

Home

Technology

Products

Pipeline

Disease

Publications

News & Investors

About Us

Careers

Privacy Policy

    ThermoDox is a registered trademark of Celsion Corporation.
    TheraPlas and TheraSilence are trademarks of Celsion Corporation.
    Avastin is a registered trademark of Genentech, Inc.
    Copyright © 2021 Celsion Corporation. All rights reserved.

    Share This
    • Twitter
    • Google+
    • Facebook
    • LinkedIn